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Abstract
Background: Propionic acidemia (PA) is a rare but severe recessive autosomal disease, presenting with non specific
signs in the first years of life. Prenatal diagnosis is invasive (amniocentesis) and limited to suspect cases. No
screening test has been described, in particular no correlations between prenatal sonography and PA have been
documented so far.
Case presentation: We report the case of a boy with fetal bilateral nephromegaly and hyperechogenic kidneys, along
with neonatal acute kidney injury; no etiology could be found in the first months of life. At 3 months of life, he presented
with tachypnea and altered mental status, which lead to the diagnosis of PA. The renal ultrasound at 8 months of life,
after a symptomatic treatment of PA had been initiated, showed a regression of the renal abnormalities.
Conclusion: This case describes PA as a novel cause of large and hyperechogenic kidneys in the antenatal period. It
suggests that, when confronted to fetal nephromegaly, hyperechogenic kidneys and risk factors of metabolic disease
such as consanguineous parents, PA should be considered, and a prenatal test should be proposed.
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Background
Propionic acidemia (PA) is a rare but severe recessive
autosomal disease caused by a deficiency of propionyl-
CoA carboxylase (PCC) alpha or beta subunits, respect-
ively encoded by PCCA and PCCB. PCC catalyzes the
conversion of propionyl-CoA to methylmalonyl-CoA,
upon the catabolism of valine, isoleucine, threonine, me-
thionine, odd-chain fatty acid, and cholesterol. A PCC
deficiency leads to the accumulation of metabolites of
propionyl-CoA in the blood and urines, such as 3-OH-
propionic acid, 3-methylcitrate, and tiglycine [1]. PA
occurs in approximately 1 in 100,000 to 150,000 new-
borns [2]. The first clinical manifestations are non spe-
cific signs of organic acidemia (vomiting, seizures,
lethargy) followed by multiple organ damages, such as
development delay, cardiomyopathy, failure to thrive,
liver and renal failure. Biologically, patients present
metabolic acidosis with an increased anion gap, hyper-
ammonemia, and high concentrations of propiopionyl-
CoA metabolites on the gas chromatograph-mass
spectrometry realized on urine. Treatment usually con-
sists of low protein diet (8 to 12 g per day initially, up to
20 g per day), biotin and L-carnitine supplementation
and intensive symptomatic care [3]. Prenatal diagnosis is
invasive, as it requires an amniocentesis, and is thus
limited to suspect cases. So far no correlation between
prenatal sonography and PA has been described. We
report the case of a boy with fetal bilateral nephromegaly
associated with PA, which illustrates that renal abnor-
malities on routine prenatal sonography should lead to a
screening of PA.
Case Presentation
The patient was a boy, born to consanguineous parents
(first degree cousins). The antenatal ultrasounds at 12
and 16 weeks of pregnancy were normal. At 24 weeks of
pregnancy, the ultrasound showed bilateral nephrome-
galy associated with undifferentiated kidneys. Fetal
weight was 467 g (45th percentile). Analysis of fetal
blood showed increased gamma glutamyl transferase
(GGT: 2674 UI/l, normal range: 10–45 UI/l), alkaline
phosphatase (330 UI/l), transaminase (ASAT: 44 UI/l),
and normal beta 2 microglobulin (4,8 mg/l). The karyo-
type was normal: 46,XY. At 36 weeks, the ultrasound
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showed bilateral nephromegaly (left kidney: 66x29x33
mm; right kidney: 63x29x30 mm; normal size for the
term: 43 mm) with undifferentiated kidneys. The blad-
der, liver, and bowel were normal. Fetal weight was
2171 g (43th percentile). Fetal biometrics were at the
20th percentile. After an amnio infusion, the quantity of
amniotic fluid normalized.
The patient was born through vaginal birth at 37 weeks
and 1 day with a birth weight of 2765 g, a head circum-
ference of 33 cm, a height of 46 cm and an APGAR
score of 8 at 1 min, 9 at 5 min and 10 at 10 min. His
first diuresis took place after 1 h and was 200 ml/day in
the neonatal period. In the first week of life, the clinical
examination was normal. Biologically he presented a
cholestasis (GGT: 1110 UI/l), with a normal conjugated
bilirubin (9 μmol/l). His creatinine at birth was 74 μmol/
l. It decreased progressively: 69 μmol/l at 3 days of life,
47 μmol/l at 6 days of life and was normal at 9 days of
life (37 μmol/l). The renal ultrasound showed bilateral
nephromegaly (Fig. 1): left kidney 55x25x23 mm; right
kidney 54x25x23 mm with hyperechogenic cortex, nor-
mal vascularization, and no pelvis renal dilatation. The
abdominal ultrasound showed a large homogenous liver,
without any dilatation of the biliary ducts. The patient
was discharged after 1 week. Initial follow-up was
uneventful.
At 3 months of life, the patient suddenly presented
with tachypnea, followed by altered mental status
(Adapted Glasgow scale according to Simon and Reilly:
6/10) and tremor of the extremities. Biological findings
showed ketoacidosis (pH: 7.17; HCO3- : 12.1 mmol/L)
and hyperammoniemia (181 μmol/L, normal range: 14–
38 μmol/L). The chromatography of plasma aminoacids
showed an increase of glycine and lysine, which led to
the diagnosis of PA. This diagnosis was confirmed by
genetic studies showing a mutation of PCCB. A whole
exome sequencing was performed and showed no renal
genetic development disease. The patient was treated
with a low-protein diet (7.5 g per day), L-carnitine
(150 mg/kg/day) and biotin (1 mg/kg/day) supplementa-
tion. Ursodesoxycholic acid (10 mg/kg/d) was intro-
duced which led to normalization of GGT at 6 months
of life (71 UI/l).
At 8 months of life, he presented no complication of
PA. The patient's renal function was normal (creatinine:
14 μmol/L, Schwartz eGFR: 135 mL/min/1.73 m2), the
ammoniemia was down to 51 μmol/L. On the renal ultra-
sound, the right kidney was measured at 56.7x30x28 mm,
and the left kidney at 57x31x29 mm (normal size for the
age: 59 mm); the kidneys were not hyperechogenic any-
more. Subsequent follow-up was that of classical PA. The
hepatic explorations were normal as well: ASAT: 23 UI/l;
ALAT: 20 UI/l; GGT: 47 UI/l; alkaline phosphatase : 262
UI/L; bilirubin < 5 μmol/l. The hepatic and biliary ultra-
sounds were normal.
At 1 year and 4 months old, the renal ultrasound con-
firmed normal renal size (right kidney 59x27x26 mm,
left kidney 62x29x27 mm), and normal echogenicity.
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Fig. 1 Comparison of renal ultrasounds at birth (a, b) and at the age of 8 months (c, d) in a patient with propionic acidemia. At birth, the patient
presented enlarged kidneys with hyperechogenic cortexes (*). (a: transverse plane, b: longitudinal plane). At the age of 8 months, kidney size was
normal, and the cortexes were normoechogenic (<). (c: transverse plane, d: longitudinal plane)
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Discussion and Conclusions
Hyperechogenic and large kidneys are described in differ-
ent pathological groups, including renal ciliopathies. They
are mainly divided into autosomal dominant and recessive
polycystic kidney disease [4], glomerulocystic kidney dis-
ease (Ivermark II syndrome, trisomy 13 and 18, Beemer
Syndrome), medullary cystic dysplasia (Bardet-Biedl syn-
drome, Meckel-Gruber syndrome, Beckwith-Wiedmann
syndrome) [5], renal dysplasia, multicystic dysplastic kid-
neys and congenital infections (e.g., cytomegalovirus and
candida). Noteworthy, in none of these diseases, a regres-
sion of the nephromegaly or of the hyperechogenic abnor-
mality has been described, as opposed to what was
observed in the patient reported here.
In some rare cases, renal failure has been described in
patients with PA [6, 7]. The evolution of the patient is
quite similar to the case described in [7]. Indeed, both
patients presented renal failure at birth. Because of the
renal failure severity, the patient in [7] required periton-
eal dialysis. However both patients showed regression of
the renal failure in a short time. Furthermore, in the case
reported here, the ultrasound abnormalities disappeared
with the normalization of the renal function. At 8 months
of life, the kidneys of the patient were normal on the ultra-
sound, as well as his creatinine levels. In [7], peritoneal
dialysis was stopped, and the patient regained normal
renal function.
The pathophysiology of the renal damage caused by
PA is unclear. However, renal failure due to tubuloin-
terstitial nephritis is a known complication of methyl-
malonic acidemia (MMA) [2]. A study of MMA Mut
−/− mice, an animal model for MMA, showed the pres-
ence of megamitochondria in renal cells of the proximal
tubule [8]. Those mices developed tubulointerstitial
renal disease. Furthermore, respiratory chain dysfunc-
tion, evidence of oxidative stress and megamithochon-
dria were also found in MMA Mut −/− mice liver cells.
The liver of a patient suffering from MMA was ana-
lyzed and displayed similar morphological and enzym-
atic finding as those observed in the murine tissue [8].
The role of oxidative stress as a result of mitochondrial
dysfunction as been observed in PA [9], and could par-
ticipate to the pathophysiologic process of the renal
damage that was observed in the patient. Furthermore,
a biopsy performed in a patient with classical PA who
presented with progressive chronic kidney disease in
the third decade of life showed tubular cells exhibiting
focally enlarged mitochondria with disorganized cristae
in electron microscopy [10]. These results suggest that
a mitochondrial disease of the tubulointerstitial seg-
ment of the kidneys could account for kidney disease in
PA, but need to be confirmed in other patients.
Prenatal diagnosis of PA consists of the measurement of
enzyme activity or methylcitric acid in cultured amniotic
fluid cells, or mutation analysis in fetal DNA [2]. Because
of the risks inherent to amniocentesis, prenatal diagnosis
of PA is proposed to very few families, most of them
with prior metabolic diseases. Importantly, an early
diagnosis of PA in neonates is associated with a lower
mortality rate, even if it has no proven impact on the
morbidity in survivors [11].
Our report describes PA as a novel cause of large and
hyperechogenic kidneys in the antenatal period. It sug-
gests that, when confronted to large and hyperechogenic
kidneys on fetal ultrasound, once the main differential
diagnoses have been ruled out, a metabolic disease such
as propionic acidemia should be considered, and a pre-
natal test should be proposed.
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